Monoclonal Rat anti‑Mouse HAVCR2 / TIM‑3 Antibody (clone 11n191, PerCP, aa20‑193) LS‑C184909
Monoclonal Rat anti‑Mouse HAVCR2 / TIM‑3 Antibody (clone 11n191, PerCP, aa20‑193) LS‑C184909
Antibody:
HAVCR2 / TIM-3 Rat anti-Mouse Monoclonal (aa20-193) (PerCP) (11n191) Antibody
Format:
Peridinin-chlorophyll-protein, Unmodified
Overview
Antibody:
HAVCR2 / TIM-3 Rat anti-Mouse Monoclonal (aa20-193) (PerCP) (11n191) Antibody
Format:
Peridinin-chlorophyll-protein, Unmodified
Specifications
Description
TIM-3 antibody LS-C184909 is a PerCP-conjugated rat monoclonal antibody to mouse TIM-3 (HAVCR2) (aa20-193). Validated for Flow.
Target
Mouse HAVCR2 / TIM-3
Synonyms
HAVCR2 | HAVcr-2 | KIM-3 | Kidney injury molecule-3 | T cell immunoglobulin mucin 3 | Tim-3 | TIMD3 | T-cell membrane protein 3 | TIM3 | TIMD-3 | T cell immunoglobulin mucin-3 | CD366
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Clonality
IgG2a
Monoclonal
Conjugations
Peridinin-chlorophyll-protein
Purification
Protein G purified
Immunogen
Recombinant corresponding to aa20-193 from mouse TIM-3 expressed in NSO cells (Q8VIM0).
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
Saline, 0.09% Sodium Azide, 0.5% BSA
Storage
May be stored at 4°C before opening. DO NOT FREEZE! Stable at 4°C as an undiluted liquid. Dilute only prior to immediate use.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin
Species:
Mouse
Applications:
Flow Cytometry
Species:
Human
Applications:
Flow Cytometry
Species:
Human
Applications:
Western blot
Species:
Mouse
Applications:
IHC, Flow Cytometry
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/25/2024